Hergenreder, Emiliano
Minotti, Andrew P.
Zorina, Yana
Oberst, Polina
Zhao, Zeping
Munguba, Hermany http://orcid.org/0000-0002-8480-8423
Calder, Elizabeth L.
Baggiolini, Arianna http://orcid.org/0000-0002-2476-561X
Walsh, Ryan M.
Liston, Conor http://orcid.org/0000-0002-1639-5401
Levitz, Joshua
Garippa, Ralph
Chen, Shuibing http://orcid.org/0000-0002-6294-5187
Ciceri, Gabriele http://orcid.org/0000-0002-8481-9771
Studer, Lorenz http://orcid.org/0000-0003-0741-7987
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG054720, F31AG067709)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R01NS128087)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH116590)
European Molecular Biology Organization (ALTF 311-2015)
New York State Stem Cell Science (C32559GG)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P500PB_203107)
Article History
Received: 17 May 2021
Accepted: 13 October 2023
First Online: 2 January 2024
Competing interests
: L.S., E.H. and G.C. are listed as inventors on a patent application filed by MSKCC and related to the findings of the present study. L.S. is a co-founder of BlueRock Therapeutics and DaCapo Brainscience.